Tradestie Institutional Equity Comparison Engine

AQST vs NUVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AQST Overall Edge

AQST Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aquestive Therapeutics, Inc. Common Stock (AQST) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus NUVB at N/M Forward P/E and -61.2% operating margin (+242.6% YoY). In options structure, AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro) against NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AQST N/M vs NUVB N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -114.1% vs -61.2% ยท YoY -41.0% vs +242.6%
Momentum & Technical Winner AQST
1Y -40.6% vs -46.9% ยท 52W Pos 14% vs 2%
Options & Structure Winner AQST
BREAKDOWN (64th %ile IV) vs BREAKDOWN (26th %ile IV)
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.46
-6.61% 1D
Market Cap $465.7M
1M Return -16.22%
1Y Return -40.65%
Forward P/E N/M
Unified AI Score
62.9 / 100 BUY
Tech 54.0 Fund 68.0 Flow 68.0 Mom 60.0
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AQST -40.65% NUVB -46.85% Spread: +6.2 pp (AQST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AQST Revenue NUVB Revenue AQST Op. Margin NUVB Op. Margin Margin Edge
FY2018 $70M N/A -72.6% N/A AQST
FY2019 $50M N/A -100.1% N/A AQST
FY2020 $50M N/A -93.6% N/A AQST
FY2021 $50M N/A -68.2% N/A AQST
FY2022 $50M N/A -88.2% N/A AQST
FY2023 $50M N/A -29.9% N/A AQST
FY2024 $60M $10M -53.5% -7527.3% AQST
FY2025 $40M $60M -159.5% -338.7% AQST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AQST (3) vs NUVB (5)
Institutional Metric AQST NUVB Criterion Row Winner
Market Capitalization Scale $465.7M $1.3B Larger Scale NUVB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -41.0% +242.6% Higher Growth NUVB
Operating Margin (TTM) Profitability -114.1% -61.2% Higher Margin NUVB
Net Profit Margin Profitability -162.3% -67.4% Higher Margin NUVB
Return on Equity (ROE) Capital Efficiency 0.0% -49.1% Higher ROE AQST
52-Week Range Position Momentum 14% ($3โ€“$7) 2% ($4โ€“$10) Stronger Trend AQST
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 56% Vol 1.52ฮฒ ยท 55% Vol Lower Realized Risk NUVB
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 61.0 / 100 (BUY) Higher Composite AQST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AQST vs NUVB Buy Guide
AQST BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 64th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AQST nor NUVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.